Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04333810 · ClinicalTrials.gov registry record
Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 8
- Enrollment target
NCT04333810: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT04333810 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04333810 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Inflammatory bowel disease (IBD) has become a more prominent disease in the US population, with more than 3 million adults in the US affected. To manage this disease effectively, physicians tend to need to have a multidisciplinary approach as there are many psychosocial implications of chronic gastrointestinal illnesses like Crohn's and Ulcerative Colitis. Recent literature has supported the desire for telemedicine and remote physiologic monitoring for such patients to allow the patient to be more active in their treatments and make physicians more aware of what their bodies are doing from a physiologic perspective. Whoop is a new device founded in 2011 that has grown in popularity for its ability to accurately measure sleep patterns, resting heart rate, and heart rate variability (HRV) amongst other various physiologic measurements. Newer literature supports that depressed heart rate variability can correlate to disease flares such as heart failure exacerbations. The study investigators proposed that using remote physiologic monitoring in the IBD population along with their symptoms can help predict disease severity and potentially lead to earlier interventions if correlations are accurate. It can also spark interest in the younger generation for remote physiologic monitoring and telemedicine, which is believed to be beneficial in patients with chronic illnesses.
Primary Outcome
Inflammatory Bowel Disease flares will be assessed by symptomatology and verified by colonoscopic biopsies to confirm active disease, reemergence of disease, or new disease.
Interventions
- DEVICE Whoop strap 3.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-07-31 |
What the finished NCT04333810 record still lists
NCT04333810 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Whoop strap 3.0 is the first listed.
NCT04333810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04333810 about?
NCT04333810 is a clinical study titled "Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study". Inflammatory bowel disease (IBD) has become a more prominent disease in the US population, with more than 3 million adults in the US affected. To manage this disease effectively, physicians tend to need to have a multidisciplinary approach as there are many psychosocial implications of chronic gastr...
What is the current status of trial NCT04333810?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2020-10-01. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04333810?
The interventions under investigation include: Whoop strap 3.0 (DEVICE).
Who is sponsoring clinical trial NCT04333810?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI